Special Considerations in the Management of HIV-Infected Patients From Minority Communities
Summary
- ECHO and THRIVE compared rilpivirine with efavirenz in treatment-naive patients receiving emtricitabine/tenofovir (ECHO) or emtricitabine/tenofovir DF, lamivudine/zidovudine, or abacavir/lamivudine (THRIVE)[Cohen 2012]
- Virologic response rates were lower in blacks compared with Asians or whites, likely due to higher rates of discontinuation and virologic failure among black patients[Hodder 2013]
- No significant differences in safety outcomes by race
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content